Duprost® Сapsules 1×30

Dutasteride 0.5mg

From USD $35.00

Duprost capsules 0.5mg contain dutasteride that is used to treat benign prostatic hyperplasia (BPH or enlarged prostate) and male pattern baldness.

Duprost capsules 0.5mg work by inhibiting the formation of the male hormone dihydrotestosterone (DHT), which causes enlarged prostate and hair loss.

Duprost capsules with dutasteride 0.5mg are not used to treat hair loss in women.

Brand name: Avodart
Items:3 - 5 5%
Items:6 - 9 10%
Items:10 + 15%


What is Dutasteride 0.5mg Duprost | Avodart Generic

Duprost capsules 0.5mg are used to treat benign prostatic hyperplasia (BPH), which is an enlarged prostate gland. Duprost capsules 0.5mg help to shrink the prostate and reduce the risk of urinary retention caused by restricted urine flow as the prostate gland becomes enlarged and presses against the urethra (urine outlet tube from the bladder), which helps urine to flow more easily, prevents urine backlog in the bladder and restores bladder control. This relieves symptoms like the need for frequent urination, inability to empty the bladder, strain, and difficulty passing urine.

The improved urine flow and reduction in symptoms may reduce the need for surgery due to moderate to severe symptoms of BHP. As a side effect of its intended use, Duprost capsules 0.5mg are also used to treat male pattern hair loss (androgenetic alopecia) by increasing hair growth and preventing further hair loss from all areas of the scalp, including the front. This can reverse balding in men with mild to moderate hair loss but does not restore hair that has been lost for a long time. Duprost capsules 0.5mg are not used to treat hair loss in women.

Warning: Exposure of women – Risk to male fetus: Dutasteride is absorbed through the skin. Therefore, women who are pregnant or may be pregnant should not handle dutasteride soft gelatin capsules because of the possibility of absorption of dutasteride and the potential risk of a foetal anomaly to a male foetus.

Brand name: Avodart, Jalyn.

How Dutasteride 0.5mg Duprost | Avodart Generic work

Duprost 0.5mg capsules contain dutasteride that specifically inhibits the action of both forms (type I and type II) of the enzyme 5α-reductase, that convert the male hormone testosterone to dihydrotestosterone (DHT) in the skin and the liver. DHT is the androgen primarily responsible for the development and growth of the prostate gland. DHT also causes benign prostatic hyperplasia (BPH) which is when the prostate becomes enlarged.

Duprost capsules 0.5mg reduce the levels of DHT in the blood, so that prostate growth is no longer stimulated in men with BPH allowing the enlarged prostate to shrink. DHT, which is also found in hair follicles, is the androgen responsible for hair loss, as it causes hair follicles in the scalp to gradually shrink producing smaller and thinner hairs, which eventually do not emerge from the follicle. Duprost capsules 0.5 mg (Avodart alternative) reverses the balding process as it blocks the build-up of DHT in the hair follicles of the scalp, allowing the hair to grow normally.

Treating hair loss with Dutasteride 0.5mg Duprost, Avodart Alternative

Duprost capsules 0.5mg contain Dutasteride 0.5 mg that is used to treat male pattern hair loss. Duprost capsules 0.5mg specifically inhibit the action of both forms (type I and type II) of the enzyme 5α-reductase that converts the male hormone testosterone to dihydrotestosterone (DHT), which is found in hair follicles and is the androgen that is responsible for hair loss. DHT causes hair follicles in the scalp to gradually shrink producing smaller and thinner hairs, which eventually do not emerge from the follicle. Duprost capsules 0.5 mg reverses the balding process as it blocks the build-up of DHT in the hair follicles of the scalp, allowing the hair to grow normally.

Side effects of Dutasteride 0.5mg Duprost, Avodart

The most commonly reported side effects when taking Duprost capsules 0.5mg include temporary impotence (whilst continuing on treatment) and low libido. Less common side effects include breast tenderness and enlargement (gynecomastia) and itchy skin rash.

When should Dutasteride 0.5mg Duprost, Avodart not be used

You should not use Duprost capsules 0.5mg if you are:

  • A woman, Duprost is not intended for use by women and can be harmful to an unborn child
  • Allergic to dutasteride or any other ingredient in Duprost
  • Taking medication that may interact with Duprost and may increase your risk for side-effects, including verapamil or diltiazem (for high blood pressure), ritonavir or indinavir (for HIV), itraconazole or ketoconazole (for fungal infections) nefazodone (an antidepressant).

How to use Dutasteride 0.5mg Duprost

You should take capsules Duprost 0.5mg with a glass of water once a day with or without food, for up to 6 months or longer, as recommended by your doctor. Do not chew the capsule or open it, as this may make your mouth or throat sore. You should continue to take Duprost capsules 0.5mg for as long as your doctor recommends, which may be for 3 months or longer. It can take 6 months or more for Duprost capsules 0.5mg to improve symptoms of BPH, as the prostate shrinks slowly and if you stop taking Duprost capsules during this time, your prostate makes start to grow again. It can take several months for new hair to grow and if you stop taking your Duprost capsules 0.5mg tablets during this time, hair loss may resume.

You should continue to take Duprost capsules 0.5mg for as long as your doctor recommends, which may be for 3 months or longer.

If you miss a dose of Duprost capsules 0.5mg take it as soon as you remember, unless it is time to take the next dose, then skip the missed dose. Do not take a double dose.

Keep your Duprost capsules 0.5mg in their blister packs and store in a cool dry place where the temperature stays below 30°C. Keep away from direct sunlight.



Cipla Limited is an Indian multinational pharmaceutical and biotechnology company, headquartered in Mumbai, India. Cipla primarily develops medicines to treat respiratory, cardiovascular disease, arthritis, diabetes, weight control and depression; other medical conditions. Cipla is a leading global pharmaceutical company, dedicated to high-quality, branded and generic medicines. We are trusted by healthcare professionals and patients across geographies. Over the last 8 decades, we have strengthened our leadership in India’s pharmaceutical industry and fortified our promise of ‘Caring for Life’. We are now strengthening our global focus by consolidating and deepening our presence in the key markets of India, South Africa, the US, and other economies of the emerging world Cipla’s state-of-the-art manufacturing facilities are cGMP compliant in conformity with national and international standards. Several dosage forms and APIs manufactured at these facilities continue to be approved by major international regulatory agencies including the US FDA, MHRA (UK), TGA (Australia), Federal Ministry of Health-Germany, MCC (South Africa), the Department of Health (Canada), INVIMA (Columbia) ANVISA (Brazil), the Danish Medical Agency, WHO and Ministry of Health of various countries.

Dr. Reddy's Labs

Dr. Reddy's Laboratories is an Indian multinational pharmaceutical company based in Hyderabad, Telangana, India. The company was founded by Anji Reddy, who previously worked in the mentor institute Indian Drugs and Pharmaceuticals Limited, of Hyderabad, India. Dr. Reddy's manufactures and markets a wide range of pharmaceuticals in India and overseas. The company has over 190 medications, 60 active pharmaceutical ingredients (APIs) for drug manufacture, diagnostic kits, critical care, and biotechnology products. As of 31st March 2015, Dr. Reddy's Laboratories had an intellectual capital of 1,200+ scientists. The company has 23 manufacturing facilities (17 in India and 6 in USA, UK and China), supported by 5 technology development centers (2 in India and 3 in USA, UK and Netherlands), 2 integrated product development facilities and 3 R&D centers. The company's offerings cover active pharmaceutical ingredients, branded formulations, generic drugs, biologics, specialty products and new chemical entities (NCE) that are sold in North America, Europe and the emerging markets of Asia, Africa and South America. Ask any of the 20,000 employees at Dr. Reddy’s why they come to work every day, and you are bound to hear, because ‘Good Health Can’t Wait.’ These simple words describe the deep-rooted belief that drives us. Sometimes, the simplest words describe the most profound truths. 'Good Health’ is always our goal. We see medicines not just as molecules, but as a means to help patients regain their health. As a leader in the pharmaceutical industry, we realize our unique role; we have the ethical and moral imperative to ensure good health can be delivered to those who need it, and to promote wellness among them. 'Can't Wait’ reflects our commitment to act with speed to find innovative solutions that address the unmet needs of patients, and to accelerate access to much-needed medicines for people around the world. Our belief is guided by our principles - Empathy and Dynamism - which provide both guidance for our current behavior and inspiration for our future actions. Dr. Ressy's Promises What we do to be true to our belief and to achieve our purpose is driven by our promises: Bringing expensive medicine within reach Addressing unmet patient needs Helping patients manage the disease better Enabling and helping our partners ensure that our medicines are available where needed Working with partners to help them succeed

Sun Pharma

Sun Pharmaceutical Industries Limited is an Indian multinational pharmaceutical company headquartered in Mumbai, Maharashtra that manufactures and sells pharmaceutical formulations and active pharmaceutical ingredients (APIs) primarily in India and the United States. Sun Pharma Laboratories Limited ("SPLL" or "Company") is a pharmaceutical company having registered office in Mumbai, Maharashtra. The Company manufactures and markets pharmaceutical products in India. It was incorporated on January 17, 1997. On March 9, 2012, it became a wholly owned subsidiary of Sun Pharmaceutical Industries Limited (SPIL). SPLL is engaged in the business of manufacturing and promoting Branded Generic pharmaceutical products and has a market share of 5.6% as per AIOCD AWACS ‐October 2015. The Company has four plants located in Sikkim and Jammu. It has a strong foothold in the therapeutic segments of Neurology & Psychiatry, Central Nervous System, Cardiology, Gastroenterology, Diabetes, Gynecology etc. The Company is a market leader in India in the chronic segment, which contributes over 60% of its revenue as per AIOCD AWACS ‐October 2015. It offers a complete therapy basket with specialization in technically complex products. Among the country’s top 300 pharmaceutical brands, SPLL owns 19 brands. It has a strong field force of over 3,200 people who promote products to over 150,000 doctors across India. The field force has well-trained sales representatives with a strong track record of performance and enjoys one of the highest productivity amongst Indian pharmaceutical companies. The Company has consistently outperformed the average industry growth over years. As per February 2015 SMSRC report, the Company was ranked No.1 by prescriptions with 7 class of specialist doctors.

Additional Information


Each soft gelatin capsule contains

Dutasteride 0.5mg


There are no reviews yet.

Be the first to review “Duprost® Сapsules 1×30”

Your email address will not be published. Required fields are marked *